OsNovum

OsNovum

Early Stage

We improve skeletal health to extend lifespan and increase quality of life

We improve skeletal health to extend lifespan and increase quality of life

Overview

Raised to Date: Raised: $204,350

Total Commitments ($USD)

Platform

Wefunder

Start Date

12/01/2020

Close Date

03/31/2021

Min. Goal
$60,750
Max. Goal
$1,070,000
Min. Investment

$100

Security Type

Equity - Preferred

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$25.00

Early Bird Valuation

$11,999,520

Pre-Money Valuation

$14,400,000

Rolling Commitments ($USD)

Status
Funded
Reporting Date

04/06/2021

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$1,717

# of Investors

146

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2020

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B

Margin

High

Capital Intensity

High

Location

Henderson, Nevada

Business Type

Growth

OsNovum, with a pre-money valuation of $14.4 million, is raising funds on Wefunder. The company has developed a patented-technology to regenerate bones affected by osteoporosis. The technology aims to improve skeletal health and improve the lifespan and quality of life. Gregory Steiner and Roslynn Steiner founded OsNovum in June 2020. The current round of crowdfunding has a minimum goal of $60,750 and a maximum goal of $1,070,000, and the proceeds will be used for FDA tests, ISO certification, regulatory submission, production equipment, product delivery systems, capital improvements, and salaries. OsNovum’s technology is already cleared by the FDA for maxillofacial use and waiting for clearance for skeletal use. The company plans to launch specialty clinics based on its technology.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$0

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$100

$0

Accounts Receivable

$0

$0

Total Assets

$0

$0

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 12/01/2020
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
OsNovum on Wefunder
Platform: Wefunder
Security Type: Equity - Preferred
Valuation: $14,400,000
Price per Share: $25.00

Follow company

Follow OsNovum on Wefunder

Buy OsNovum's Deal Report

Warning: according to the close date for this deal, OsNovum may no longer be accepting investments.

OsNovum Deal Report

Get KingsCrowd’s comprehensive report on OsNovum including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether OsNovum is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the OsNovum deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge